As genome sequencing becomes more affordable should you do it?
photo: Mopic
As genome sequencing drops to a price that’s palatable for more consumers, two doctors debate whether those without medical conditions should do it. Read more »
Biotech startup Syapse wants to be Salesforce.com for our genomes
photo: Shutterstock / kentoh
A startup called Syapse is trying to bring the world of “omics” — the study of all our genomes, biomes, proteomes and other “omes” — under control with a new data management platform based on some of the general techniques that also power Facebook’s Graph Search. Read more »
VC investments see downturn in 2012, do 10 percent less in funding than previous year
How did venture capital stack up in 2012 compared to 2011? A new report taking a look at all VC investments for the past year breaks down some of the trends, noting overall decreases in funding but a few areas that did well. Read more »
Why data is the key to better medicine — and maybe a cure for cancer
photo: The Cancer Genome Atlas
There’s no shortage of great minds using big data techniques to improve the quality of our medical treatments, but sometimes they can’t get access to the data they need most. Improving access to genetic data, for example, might just help cure cancer. Read more »
Major investments show promise of big data in biotech
Cloud-based DNA-sequencing specialist DNAnexus has closed a $15 million second round led by Google Ventures and TPG Biotech. Elsewhere, we learned Wednesday that agribusiness giant Monsanto has deployed Cloudant’s NoSQL database as the underpinning of the company’s genomics system. Read more »
